Assay and Drug Development Technologies Impact Factor 2026: 2.60, Quartile

Publishing your own paper?

Get it ready for the right journal with a PhD expert in your field.

Manuscript Auditing

A PhD reviewer in your exact area sends a structured, section-by-section critical review.

AI plagiarism and similarity report included
Secure, confidential upload

Audit duration: within 1 weekCheck price →

If the journal needs LaTeX

LaTeX Template Conversion

We convert your manuscript into the LaTeX template your target journal requires.

Check price →

If your paper was out of scope

Journal Selection & Submission

Up to 5 journals matched to your indexing (SCIE / Scopus) and quartile
Submission handled, with weekly updates

With LaTeX conversion: within 2 Working DaysCheck price →

What is ScholarsColab?

ScholarsColab is a freelancing platform built for researchers, with a pool of research doctorates registered to mentor them. Hire one in your research area and cut your research timeline from 2 years to 2 months.

Know more →

At a glanceAssay and Drug Development Technologies is listed in SCIE, Scopus, JCR 2024. Published by Mary Ann Liebert, Inc., it has 1,444 published works, cited 27,533 times (h-index 73). Its impact factor* of 2.60 ranks it 182 of 371 in Pharmacology & Pharmacy. 15% of its recent research articles name a funder, most often National Natural Science Foundation of China. Papers by ScholarsColab mentors and the researchers we track appear here as soon as they publish in it. Data updated 22 October 2026.

Official website Check my manuscript first

Impact factor*2.60Rank 182 of 371 in Pharmacology & Pharmacy IndexingSCIEScopusJCR 2024Confirm on the official lists before you submit

RetractionsNoneNone on record under this name

01Impact factor

Impact factor of Assay and Drug Development Technologies (2026)

Impact factor (2-year)2.60calculated by ScholarsColab

Rank in category#182of 371 by citedness

h-index73

Papers published1,444cited 27,533 times

The impact factor shown here is the 2-year mean citedness: citations received in a year by the papers Assay and Drug Development Technologies published in the two previous years, divided by the number of those papers. That is the same formula as the Journal Impact Factor, calculated by ScholarsColab. The journal is listed in JCR 2024, so it also has an official Journal Impact Factor published by Clarivate, which can differ because it counts citations from Web of Science journals only.

Rank in its subject categories

Pharmacology & Pharmacyrank 182 of 371 journals
Biochemical Research Methodsrank 52 of 86 journals

Ranks here compare journals of the same Web of Science category in our data by 2-year citedness; they are not the official JCR rank.

Quartile of Assay and Drug Development Technologies

A journal's quartile (Q1 to Q4) is its position within a subject category: Q1 is the top quarter. The official quartiles are published by Clarivate in Journal Citation Reports (by Journal Impact Factor, in Web of Science categories) and by Scimago as the SJR quartile (in Scopus categories). Assay and Drug Development Technologies is listed in JCR 2024, so its JCR quartile is in Journal Citation Reports. It is indexed in Scopus, so Scimago shows its SJR quartile. ScholarsColab does not show a quartile until it can show the official one; the impact factor and rank above are calculated from open data.

Citations and papers per year

Citations per year

Papers per year

Please check the final impact factor. The impact factor and APC on this page are calculated by ScholarsColab (updated 17 October 2026) and can differ from the official values. Confirm the current impact factor and charges on the journal’s website or in Clarivate’s Journal Citation Reports before you submit.

Is your paper a fit for Assay and Drug Development Technologies?

Most desk rejections come from a scope mismatch. Compare your title and abstract with what this journal really publishes. Free, no sign-up, about 2 minutes.

Check my paper for this journal Or find journals that fit my paper

Need a faster review? The fastest journals in Pharmacology & Pharmacy accept papers in a median of 3 days.

Anti-Cancer Drugs 3 days
Alimentary Pharmacology & Therapeutics 8 days
Journal of Pharmacy And Bioallied Sciences 38 days

All fastest journals in this field

APC waivers and discounts for Assay and Drug Development Technologies

Mary Ann Liebert: liebert open access pages redirect to Sage; Sage Research4Life Group A automatic full waiver (applicability to Liebert unverified).

Check the APC for my country

02Funders

Who funds research published in Assay and Drug Development Technologies

Articles naming a funder15%of 81 recent articles

Funders named most often

National Natural Science Foundation of China2

Key R&D Program of Jining1

Zhejiang Province “Small but Strong” Clinical Cultivation Innovation Team1

Ningbo Natural Science Foundation Project1

Zhejiang Province Medical and Health Science and Technology Plan Project1

A high share of funded papers usually means the journal is a common choice for grant-supported work in its field. If your funder pays article processing charges, or your country qualifies for a waiver, check what applies to your author team with the free APC waiver checker.

Based on up to 200 research articles this journal published in the last 24 months. Not every article lists its funders, so the share can be lower than the real one. Updated: 29 October 2026.

03Indexing

Indexing of Assay and Drug Development Technologies

List	Status
Science Citation Index Expanded (SCIE)	✓ Listed
Social Sciences Citation Index (SSCI)	Not listed
Arts & Humanities Citation Index (AHCI)	Not listed
Emerging Sources Citation Index (ESCI)	Not listed
Scopus	✓ Listed
Journal Citation Reports 2024	✓ Listed

ISSN: 1540-658X
eISSN: 1557-8127
Publisher: Mary Ann Liebert, Inc. all its journals →
Subjects: Biochemical Research Methods, Pharmacology & Pharmacy

From the indexing lists used on ScholarsColab, updated 1 March 2026. Indexing can change: confirm on the Web of Science Master Journal List or the Scopus source list before submitting. Official Journal Impact Factors and JCR quartiles are published by Clarivate; the impact factor on this page is calculated by ScholarsColab (see how the impact factor works).

Verify the indexing yourself

Each link opens the official record for this journal, searched by its ISSN where we have one.

04How to submit

How to submit to Assay and Drug Development Technologies

Read the guide for authors. It sets the article types, word limit, reference style and file format that Assay and Drug Development Technologies accepts. You find it on the official website of the journal, usually under "For authors" or "Submit".
Format to the journal's style. Check whether it wants a Word file, a LaTeX file or a PDF for the first submission, and follow its reference style; many journals accept any clear format at first and ask for their style only after acceptance.
Check the fit. Read the aims and scope and a few recent issues; papers outside the scope are the most common reason for a desk rejection. The Journal Finder shows journals that published the closest work.
Check the fee. Assay and Drug Development Technologies is not a fully open access journal, so authors usually pay nothing unless they choose open access for their article or the journal charges page or colour fees. The guide for authors states the current charges.
Check your manuscript before you submit. The free Submission Readiness Check asks the seven questions our reviewers ask in every audit and takes about 2 minutes.

05Reviewer comments

Reviewer comments and rejection reasons for Assay and Drug Development Technologies

No reviewer or editor comments have been shared for this journal yet. Did you submit here? Help other researchers by sharing the comments you received, anonymously.

Across the reviewer comments researchers have shared with us, the points raised most often are figures, tables and equations (21%), literature and references (12%) and novelty and contribution (10%). Before you submit to Assay and Drug Development Technologies, a Manuscript Audit by a PhD reviewer in your area checks your paper against exactly these points.

Audit my paper before I submit →

Worried about the English? Manuscript editing by editors in your subject: see the price →

Not sure yet? Check if your paper is ready for this journal: free, no AI, under 5 seconds

06Same subject

Pharmacology & Pharmacy journals with a similar impact factor*

The journals next to Assay and Drug Development Technologies when the 354 journals of Pharmacology & Pharmacy in our data are ranked by impact factor*:

Rank	Journal	Impact factor*	Indexing	Open access
178	Current Medicinal Chemistry	2.70	SCIE	Subscription
179	Drug and Chemical Toxicology	2.69	SCIE	Subscription
180	Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy	2.67	SCIE	Subscription
181	Immunopharmacology and Immunotoxicology	2.65	SCIE	Subscription
183	Therapeutic Advances in Psychopharmacology	2.59	SCIE	Fully open access
184	JAC-Antimicrobial Resistance	2.58	ESCI	Fully open access
185	Journal of Managed Care & Specialty Pharmacy	2.56	SCIE	Subscription
186	Pharmacy	2.55	ESCI	Fully open access

*Impact factor calculated by ScholarsColab (2-year citedness), not the official Clarivate value.

FreeNo AI

Is Assay and Drug Development Technologies right for your paper? Find the right journal

Paste your title, keywords or abstract. See the journals that published the closest papers, with indexing, impact factor, review time and APC.

Try:

Publishing open access? Your author team may not have to pay the APC. Free APC waiver check for your country→

How it works

No AI or language model is used. Your words are matched against the titles of 157,115 real published journal papers, by our mentors and by other researchers (shown without names); journals are ranked by how many closely matching papers they published. Indexing comes from the SCIE, SSCI, AHCI, ESCI, Scopus and JCR 2024 lists, matched by journal name; the impact factor is calculated by ScholarsColab, not the official Clarivate value, and no quartile is shown until the official JCR or SJR quartile can be; review time is the median days from submission to acceptance (not every publisher publishes these dates). Always check a journal’s scope and current indexing before submitting.

Want a PhD expert to shortlist and handle the submission? Journal Selection & Submission matches your manuscript to up to 5 suitable journals by indexing and quartile. Check price →

07Questions

Frequently asked questions

What is the impact factor of Assay and Drug Development Technologies?

Based on ScholarsColab citation data (October 2026), the 2-year impact factor of Assay and Drug Development Technologies is 2.60: papers it published in the two previous years were cited 2.60 times on average in a year. The journal is listed in JCR 2024, so Clarivate also publishes an official Journal Impact Factor, which can differ.

What is the h-index of Assay and Drug Development Technologies?

The h-index of Assay and Drug Development Technologies is 73 (October 2026): 73 of its papers have each been cited at least 73 times. Its i10-index is 593.

What is the quartile of Assay and Drug Development Technologies?

Is Assay and Drug Development Technologies indexed in Scopus?

Yes. Assay and Drug Development Technologies appears in the Scopus list, according to the indexing lists used on ScholarsColab (updated 1 March 2026). Always confirm the current status on the official list before submitting.

Is Assay and Drug Development Technologies an SCIE journal?

Yes. Assay and Drug Development Technologies is listed in the Science Citation Index Expanded (SCIE), according to the indexing lists used on ScholarsColab (updated 1 March 2026). Always confirm the current status on the official list before submitting.

Is Assay and Drug Development Technologies in Journal Citation Reports (JCR)?

Yes. Assay and Drug Development Technologies is listed in JCR 2024, so it has a Journal Impact Factor. For the current impact factor and quartile, check Journal Citation Reports.

Does Assay and Drug Development Technologies offer an APC waiver?

Assay and Drug Development Technologies follows the policy of Mary Ann Liebert: liebert open access pages redirect to Sage; Sage Research4Life Group A automatic full waiver (applicability to Liebert unverified). No country rule: the publisher decides case by case, or has no waiver scheme. Rules verified 27 October 2026; confirm on the publisher's page.

Who funds research published in Assay and Drug Development Technologies?

15% of 81 recent research articles in Assay and Drug Development Technologies name a funder; the funders named most often are National Natural Science Foundation of China, Key R&D Program of Jining, Zhejiang Province “Small but Strong” Clinical Cultivation Innovation Team.